Such bacterial products are ligands of endogenous Toll-like receptor 4 (TLR4) triggering inflammation responses involved in NAFLD, NASH and liver fibrosis. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.